The medical term for these treatments is GLP-1 agonists, and they are changing how providers treat Type 2 diabetes and obesity
Macleod suggested calling the refined extract insulin to distinguish it from Banting and Bests original crude extract
Eli Lilly is planning to submit orforglipron (Foundayo) for the treatment of T2DM in the second quarter of 2026 under the CNPV pilot program, making it possible for the drug to receive FDA approval in late 2026
The reduction in A1C from the pill form is comparable to what we see with injectable GLP-1 drugs like Ozempic, though perhaps slightly less than whats seen with dual agonists like Mounjaro, Dr
Find out if kratom is safe/legal to use, including potential adverse effects, such as agitation, rapid heartbeat, nausea, drowsiness, seizures, and possible drug interactions